These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 22296264

  • 1. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H, Jeganathan S, Smith DE, Robertson P, Barnes T, Furner V.
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [Abstract] [Full Text] [Related]

  • 2. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E, Boschini A, Amendola A, Poletti R, Anselmi G, Begnini M, Ranghiero A, Cecconi G, Zanetti AR.
    Vaccine; 2011 Nov 15; 29(49):9209-13. PubMed ID: 21974995
    [Abstract] [Full Text] [Related]

  • 3. Immune response to 2009 pandemic H1N1 influenza virus A monovalent vaccine in children with cancer.
    Yen TY, Jou ST, Yang YL, Chang HH, Lu MY, Lin DT, Lin KH, Huang LM, Chang LY.
    Pediatr Blood Cancer; 2011 Dec 15; 57(7):1154-8. PubMed ID: 21425448
    [Abstract] [Full Text] [Related]

  • 4. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT, Guo CY, Tsai MS, Cheng YY, Lin MT, Chen CH, Shen D, Wang JR, Sung JM.
    Vaccine; 2012 Jul 13; 30(33):5009-18. PubMed ID: 22658967
    [Abstract] [Full Text] [Related]

  • 5. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP, Phoon MC, Koh GC, Chen MI, Lee VJ, Wu Y, Xie ML, Cheong A, Leo YS, Chow VT.
    Int J Infect Dis; 2012 Aug 13; 16(8):e621-7. PubMed ID: 22704721
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults.
    Hakim H, Allison KJ, Van De Velde LA, Li Y, Flynn PM, McCullers JA.
    Vaccine; 2012 Jan 20; 30(5):879-85. PubMed ID: 22155630
    [Abstract] [Full Text] [Related]

  • 7. The humoral immune response of hematopoietic stem cell transplantation recipients to AS03-adjuvanted A/California/7/2009 (H1N1)v-like virus vaccine during the 2009 pandemic.
    Engelhard D, Zakay-Rones Z, Shapira MY, Resnick I, Averbuch D, Grisariu S, Dray L, Djian E, Strauss-Liviatan N, Grotto I, Wolf DG, Or R.
    Vaccine; 2011 Feb 17; 29(9):1777-82. PubMed ID: 21216315
    [Abstract] [Full Text] [Related]

  • 8. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
    Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W.
    Vaccine; 2006 Jun 19; 24(25):5371-80. PubMed ID: 16713661
    [Abstract] [Full Text] [Related]

  • 9. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ, Müller M, Kollaritsch H, Pinl F, Schmitt B, Zeitlinger M, Loew-Baselli A, Kreil TR, Kistner O, Portsmouth D, Fritsch S, Maritsch F, Aichinger G, Pavlova BG, Barrett PN.
    Vaccine; 2012 Jun 22; 30(30):4543-51. PubMed ID: 22475864
    [Abstract] [Full Text] [Related]

  • 10. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children.
    Phongsamart W, Sirisanthana V, Wittawatmongkol O, Maleesatharn A, Sudjaritruk T, Chearskul P, Aurpibul L, Sirisanthana T, Chokephaibulkit K.
    Vaccine; 2011 Nov 03; 29(47):8705-11. PubMed ID: 21893147
    [Abstract] [Full Text] [Related]

  • 11. The antibody response to pandemic H1N1 2009 influenza vaccine in adult organ transplant patients.
    Felldin M, Studahl M, Svennerholm B, Friman V.
    Transpl Int; 2012 Feb 03; 25(2):166-71. PubMed ID: 22117586
    [Abstract] [Full Text] [Related]

  • 12. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains.
    Luytjes W, Enouf V, Schipper M, Gijzen K, Liu WM, van der Lubben M, Meijer A, van der Werf S, Soethout EC.
    Vaccine; 2012 Jul 27; 30(35):5262-9. PubMed ID: 22691431
    [Abstract] [Full Text] [Related]

  • 13. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
    Lagler H, Wenisch JM, Tobudic S, Gualdoni GA, Rödler S, Rasoul-Rockenschaub S, Jaksch P, Redlberger-Fritz M, Popow-Kraupp T, Burgmann H.
    Vaccine; 2011 Sep 16; 29(40):6888-93. PubMed ID: 21803100
    [Abstract] [Full Text] [Related]

  • 14. Reduced immune response to influenza A (H1N1) 2009 monovalent vaccine in HIV-infected Japanese subjects.
    Yanagisawa N, Maeda K, Ajisawa A, Imamura A, Suganuma A, Ando M, Takayama N, Okuno Y.
    Vaccine; 2011 Aug 05; 29(34):5694-8. PubMed ID: 21689709
    [Abstract] [Full Text] [Related]

  • 15. Immunogenicity and tolerability of an inactivated and adjuvanted pandemic H1N1 influenza vaccine, in HIV-1-infected patients.
    Tremblay CL, Rouleau D, Fortin C, Toma E, Sylla M, Cyr L, Cote S, Baz M, Sampalis J, Trautman L, Sékaly RP, Boivin G.
    Vaccine; 2011 Feb 04; 29(7):1359-63. PubMed ID: 21185423
    [Abstract] [Full Text] [Related]

  • 16. Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.
    Uno S, Kimachi K, Matsuo F, Miyazaki K, Oohama A, Kei J, Nishimura T, Odoh K, Kino Y.
    Microbiol Immunol; 2012 Dec 04; 56(12):810-6. PubMed ID: 23009167
    [Abstract] [Full Text] [Related]

  • 17. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
    Liu W, Ma MJ, Tang F, He C, Zhang XA, Jiang LF, Xin DS, Hu CY, Looman C, Cao WC.
    Vaccine; 2012 Jul 06; 30(32):4785-9. PubMed ID: 22633868
    [Abstract] [Full Text] [Related]

  • 18. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
    You FX, Sun N, Ma GY, Wang MM, Sa D, Shi C, Wu JL, Lin X, Xiao Y, Qian YH, Jiang Y, Xie J, Ji YY, Guan HX.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct 06; 25(5):351-4. PubMed ID: 22338222
    [Abstract] [Full Text] [Related]

  • 19. Immunogenicity and safety of a China-made monovalent pandemic (H1N1) 2009 influenza A vaccine in healthcare workers in Guangzhou, China.
    Zhan Y, Yang Z, Li L, Ye D, Wu H, Fu R, Zhao S, Wang Y, Zhou R, Chen R.
    Jpn J Infect Dis; 2011 Oct 06; 64(3):190-4. PubMed ID: 21617301
    [Abstract] [Full Text] [Related]

  • 20. Does vaccine dose predict response to the monovalent pandemic H1N1 influenza a vaccine in children with acute lymphoblastic leukemia? A single-centre study.
    Leahy TR, Smith OP, Bacon CL, Storey L, Lynam P, Gavin PJ, Butler KM, O'Marcaigh AS.
    Pediatr Blood Cancer; 2013 Oct 06; 60(10):1656-61. PubMed ID: 23682005
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.